Pcn78 - Evaluating the Economic Consequences of Novel Agents for Treating Hodgkin Lymphoma in Greece

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn113 - Evaluating the Economic Impact of Novel Agents for Treating Multiple Myeloma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Biologic Agents in the Management of Hodgkin Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Treating Hodgkin Lymphoma in the New Millennium: Relapsed and Refractory Disease

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma

Blood Reviews
OncologyHematology
2010English

Hodgkin Lymphoma in Pregnancy

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2013English

Classic Hodgkin Lymphoma

Mayo Clinic Proceedings
Medicine
2018English

Treatment of Relapsed and Refractory Hodgkin Lymphoma – Recommendations of the Czech Hodgkin Lymphoma Study Group

Klinicka Onkologie
Oncology
2016English

Classic Hodgkin Lymphoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy